Abatacept as GVHD Prophylaxis Phase 2

NCT01743131 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease
Malignancy

Interventions

DRUG: Abatacept
DRUG: placebo

Sponsor

Boston Children's Hospital

Collaborators

[object Object]